FASEB J.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


FJ EXPRESS SUMMARY ARTICLE
The
Full-length version of this article is also available, published online March 28, 2001 as doi:10.1096/fj.00-0625fje.
Published as doi: 10.1096/fj.00-0625fje.
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
15/7/1227
00-0625fjev1    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by SCHMIDT-OTT, K. M.
Right arrow Articles by PAUL, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by SCHMIDT-OTT, K. M.
Right arrow Articles by PAUL, M.
(The FASEB Journal. 2001;15:1227-1229.)
© 2001 FASEB

Hypoxia reverses dibutyryl-cAMP-induced stellation of cultured astrocytes via activation of the endothelin system 1

KAI M. SCHMIDT-OTT*, AN DING XU*,{ddagger}, SEBASTIAN TUSCHICK{dagger}, LUTZ LIEFELDT*, WOLFGANG KRESSE, ALEXEJ VERKHRATSKY, HELMUT KETTENMANN{dagger} and MARTIN PAUL*2

* Institute of Clinical Pharmacology and Toxicology, Freie Universität Berlin, Benjamin Franklin Medical Center, Berlin, Germany;
{dagger} Max-Delbrück Center for Molecular Medicine, Berlin-Buch, Germany; and
{ddagger} Department of Neurology, Jinan University Guangzhou, P.R. of China

2Correspondence: Institute of Clinical Pharmacology and Toxicology, Benjamin Franklin Medical Center, Freie Universität Berlin, Garystrasse 5, 14195 Berlin, Germany. E-mail: paul{at}medizin.fu-berlin.de

SPECIFIC AIMS

In this study, we addressed the hypothesis that hypoxia can induce morphological changes in cultured astrocytes (AC) similar to those observed in vivo after ischemia or hypoxia of the brain. In addition, we investigated the role of the astrocytic endothelin (ET) system in mediating this response using northern blotting, RT-PCR, ET radioimmunoassay, calcium imaging, and ET receptor antagonists.

PRINCIPAL FINDINGS

1. Hypoxia triggers a morphological transformation of AC
In culture medium under serum-free conditions, AC are characterized by a flat and polygonal cell shape (Fig. 1A ). We induced AC to acquire a stellate morphology similar to their appearance in vivo by incubating cultures with 1 mM dibutyryl-cAMP (DBcAMP) for ~24 h in serum-free medium. Exposure of these cells to hypoxia for 24 h resulted in a morphological transformation to the flat, polygonal form (Fig. 1E ). In control normoxic conditions, the stellate cell shape was preserved (Fig. 1B ). To quantify the morphological transformation, stellate cells were scored according to the criteria by Kimelberg et al., i.e., cells having two or more processes at least twice as long as the diameter of the cell body were defined as stellate.



View larger version (221K):
[in this window]
[in a new window]
 
Figure 1. Morphological alterations in AC exposed to varying experimental conditions for 24 h. A) No DBcAMP, normoxia. B) 1 mM DBcAMP, normoxia. C) 1 mM DBcAMP, 100 nM ET-1, normoxia. D) 1 mM DBcAMP, 100 nM ET-1, 5 µM PD142893. E) 1 mM DBcAMP, hypoxia. F) 1 mM DBcAMP, hypoxia, 5 µM PD142893. DBcAMP induces stellation of cultured AC (B). Hypoxia and ET-1 both reverse the DBcAMP-induced morphological changes (C, E). The effects of hypoxia and ET-1 are blocked by addition of ET receptor antagonist PD142893 (D, F).

2. ET-1 is a signaling substance to mediate the hypoxia-induced change in morphology
Cultured AC constitutively release ET into the supernatant as determined by radioimmunoassay. The peptide level in culture supernatants of normoxic AC was 2.92 + 0.20 pg/mg protein 24 h after a medium change (n=4). Hypoxia induced an increase in the level of ET to about 150%, namely, 4.23 + 0.56 pg/mg protein in the supernatants of AC exposed to 24 h of hypoxia (n=4; P<0.005).

To test whether the increased level of ET could be an astrocytic mediator of the hypoxia-induced morphological transformation, we applied exogenous ET-1 to the supernatant and analyzed the morphological appearance of AC. Addition of 100 nM synthetic ET-1 to the culture media mimicked the morphological changes induced by hypoxia (Fig, 1C). The involvement of the ET system was further substantiated by the finding that PD142893 or PD145065 (5 µM), two nonselective ET receptor antagonists, blocked the effects of hypoxia (Fig. 1F ) or ET-1 (Fig. 1D ) on astrocyte morphology.

To examine the molecular changes in the astrocytic ET system, we performed Northern blots and RT-PCR. Prepro ET-1 mRNA was detectable in extracts of cultured AC using Northern analysis. Exposure to hypoxia for 24 h increased prepro ET-1 mRNA levels significantly to about 300% of baseline levels (Fig. 2 ). Prepro ET-3 mRNA and ECE-1 mRNA were not detectable by Northern blots. However, using RT-PCR, we were able to amplify both, prepro ET-3 and ECE-1 transcripts, suggesting a low baseline expression level of these ET system components. ECE-2 mRNA was present in normoxic and hypoxic AC without a significant difference in the mRNA level, as determined by Northern analysis (Fig. 2) .



View larger version (69K):
[in this window]
[in a new window]
 
Figure 2. Effect of hypoxia on astrocytic ET system gene expression. Representative Northern blots for prepro ET-1, ETAR, ETBR, and ECE-2 on total RNA extracted from AC after exposure to 24 h of hypoxia or control conditions. 18S and 28S rRNA was used for standardization. Hypoxic AC contain increased amounts of prepro ET-1 mRNA and decreased amounts of ET receptor mRNAs. ECE-2 mRNA levels remain unchanged.

3. ET receptors are down-regulated on the trancriptional level, but remain functional on hypoxic AC
Under normoxic conditions, ETA receptor (ETAR) and ETB receptor (ETBR) mRNAs were detectable in Northern blots of total RNA from cultured AC. Hypoxia induced a significant down-regulation of the ETAR and ETBR mRNA, namely, to about 20% of their baseline levels (Fig. 2) . Both ETAR and ETBR are G-protein-coupled receptors that lead to a release of Ca2+ ions from internal stores. To investigate, whether the down-regulation of ETAR and ETBR mRNA detected by Northern blots affected receptor functionality, we tested for the cells‘ ability to respond with an increase in Ca2+ after application of ET. Extracellular application of 100 nM of the nonselective ET isoform ET-1 triggered a [Ca2+]i transient in ~61 ± 36% of the hypoxic cells as compared to 96±9% of normoxic AC. To test for viability of individual cells, ATP (100 µM) was delivered 3–5 min after the ET-application, which generated an easily detectable [Ca2+]i response. These results demonstrate that ET receptors, although down-regulated on the mRNA level, still mediate physiologic responses in the majority of hypoxic AC.

CONCLUSIONS

Many authors have discussed the morphology of AC in a brain that has been subjected to ischemia or hypoxia. Loss of astrocytic processes during global cerebral ischemia was first recognized by Alzheimer in 1910. He noted that AC can undergo a process he termed ‘clasmatodendrosis’, which results in these cells assuming an amoeboid shape with a clear reduction in surface area. Recent ultrastructural studies revealed the disappearance of astrocytic processes from adjacent dendrites after hypoxia in rats. These changes after hypoxia are believed to promote neuronal deterioration by reducing astrocytic uptake of neurotransmitters and potassium. To isolate these astrocytic responses from the cerebral microenvironment and to investigate the underlying molecular mechanisms, it is important to establish an in vitro model. However, researchers had so far been unable to observe morphological changes in cultured AC subjected to hypoxia. In this study, we used cultured AC pretreated with DBcAMP. This substance induces a process-bearing, differentiated appearance of cultured AC. When subjected to hypoxia for 24 h, AC reassumed the flat, polygonal appearance of untreated cells. We therefore were able to generate an experimental model mimicking clasmatodendrosis in vitro showing that it can take place independent of the cerebral microenvironment.

AC produce components of the ET system. ET has been previously linked to morphological alterations in AC. Therefore, we sought to characterize the astrocytic ET system responses to hypoxia and their relation to the morphological transformation. Northern blotting and RT-PCR experiments, ET radioimmunoassay, and functional experiments on ET receptors indicate an activation of the astrocytic ET system in response to hypoxia. The amounts of ET-1 in the supernatants and of prepro ET-1 mRNA in cell extracts are increased in hypoxic cells. At the same time, ET receptors are down-regulated on the transcriptional level, but remain functionally active. Most important, when we applied ET receptor antagonists, we were able to prevent the morphological transformation of hypoxic AC. The morphological transformation of hypoxic AC, therefore, can be causally linked to the activation of the ET system and blocked by specific pharmacological intervention.



View larger version (40K):
[in this window]
[in a new window]
 
Scheme 1. Schematic diagram of the findings in this study. Hypoxia induces a morphological transformation of cultured AC pretreated with DBcAMP from a process-bearing to a flat and polygonal cell shape. In addition, the ET system in these cells is activated in response to hypoxia (green arrows). PD142893 and PD145065, two nonselective ET receptor antagonists, block morphological transformation in response to hypoxia (red arrows). These findings indicate that hypoxia via activation of the ET system triggers changes of astrocyte morphology.

FOOTNOTES

1 To read the full text of this article, go to http://www.fasebj.org/cgi/doi/10.1096/fj.00-0625fje ; to cite this article, use FASEB J. (March 28, 2001) 10.1096/fj.00-0625fje





This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
15/7/1227
00-0625fjev1    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by SCHMIDT-OTT, K. M.
Right arrow Articles by PAUL, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by SCHMIDT-OTT, K. M.
Right arrow Articles by PAUL, M.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS